Controlled Substances Act — Lanton Law Blog

U.S. Houses Passes the MORE Act Helping Cannabis Stakeholders

The U.S. House has passed the Marijuana Opportunity Reinvestment and Expungement Act otherwise known as the MORE Act. The proposed bill removes marijuana from the list of scheduled substances under the Controlled Substances Act and eliminates criminal penalties for an individual who manufactures, distributes, or possesses marijuana.

cannabis, CBD, Congress, healthcare, hempRon LantonApril 7, 2022Marijuana Opportunity Reinvestment and Expungement Act, MORE Act, Controlled Substances Act, U.S. House of Representatives, U.S. Senate, Cannabis

New Congressional CBD Bill Introduced to Give Policy Clarity for CBD Products

Congress has introduced the CBD Product Safety and Standardization Act “that will establish federal standards for CBD food and beverage products to protect consumers and provide marketplace stability for farmers, producers, and retailers.”

cannabis, CBD, Congress, FDA, pharmaceuticals, pharmacyRon LantonDecember 6, 2021CBD, CBD Product Safety and Standardization Act, Controlled Substances Act, Congress, 2018 Farm Bill, FDA